Companies / Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.

Nasdaq: NRIXCIK 1549595BRISBANE, CAnurixtx.com ↗

Financials · FY2025

Revenue$83.98M
Net income$-264.46M
Total debt—
Cash$67.69M
Diluted EPS$-3.05
Shares outstanding103.8M

Ownership

103.8M shares outstanding · as of Jun 30, 2026
0.19%Insiders
Ownership
Insiders0.19%195,033
Institutions108.73%112,840,998
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Hansen GwennChief Scientific Officer
0.11%115,005
van Houte HansChief Financial Officer
0.04%45,427
Ring ChristineChief Legal Officer
0.03%34,601
Gregory Julia PDirector
——
Reinsdorf Judith ADirector
——
Sands Arthur TCEOPresident, CEO · Director
——

Institutional holders 190

View all →
HolderValue% of shares
BlackRock, Inc.$212.77M8.45%
Redmile Group, LLC$153.54M7.80%
Deep Track Capital, LP$133.48M6.78%
State Street Corporation$113.47M4.51%
Vanguard Group Inc$112.86M5.73%
Morgan Stanley$92.59M4.70%
Vestal Point Capital, LP$88.97M4.52%
Fmr LLC$80.32M4.08%
Baker Bros. Advisors LP$72.21M4.49%
Pictet Asset Management Holding SA$65.78M3.34%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 9, 2026Ring Christine
Executive
SellCommon Stock$237.6K-14K
-25.01%
42,749
0.04% of shares
medium
Mar 2, 2026Ring Christine
Executive
SellCommon Stock$125.8K-8K
-19.06%
34,601
0.03% of shares
medium
Jan 30, 2026Hansen Gwenn
Executive
SellCommon Stock$79.5K-5K
-5.42%
83,770
0.08% of shares
low
Jan 30, 2026Ring Christine
Executive
SellCommon Stock$71.9K-4K
-7.05%
57,098
0.06% of shares
low
Jan 20, 2026Ring Christine
Executive
SellCommon Stock$69.3K-4K
-6.88%
50,897
0.05% of shares
low
Jan 30, 2026van Houte Hans
Executive
SellCommon Stock$59.5K-4K
-7.31%
45,500
0.04% of shares
low
Feb 3, 2026Hansen Gwenn
Executive
ExerciseCommon Stock$26.3K+31K
+37.45%
115,005
0.11% of shares
low
Jan 20, 2026Ring Christine
Executive
ExerciseCommon Stock$7.0K+4K
+7.39%
54,657
0.05% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Baker Bros. Advisors LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NRIX——67080M103—